Gina Kolata and Pam Belluck Post1 Posts Posts Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
